Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Diagnostics(Electronic Edition) ›› 2018, Vol. 06 ›› Issue (03): 198-201. doi: 10.3877/cma.j.issn.2095-655X.2018.03.012

Special Issue:

• Clinical Study • Previous Articles     Next Articles

Diagnostic features of insulin autoimmune syndrome caused by Methimazole

Panwei Mu1,(), Ying Tan1, Longyi Zeng1   

  1. 1. Department of Endocrinology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2018-01-17 Online:2018-08-26 Published:2018-08-26
  • Contact: Panwei Mu
  • About author:
    Corresponding author: Mu Panwei, Email:

Abstract:

Objective

To explore the diagnostic features of insulin autoimmune syndrome (IAS).

Methods

A retrospective analysis was performed in one patient diagnosed as IAS in Department of Endocrinology of the Third Affiliated Hospital of Sun Yat-sen University. Then the relevant literatures were reviewed.

Results

A 19-year female patient with Graves disease suffered from serious hypoglycemia after she had taken Methimazole for more than ten days. The insulin releasing index was 4.13 when her blood glucose was 2.73 mmol/L. The ratios of fasting insulin/fasting C-peptide were within 8.20-15.12. The insulin auto-antibody (IAA) was positive. The patient′s pancreas was normal in abdomen enhanced MR.

Conclusion

IAS should be considered when a patient with autoimmune disease suffers from hypoglycemia, especially while the patient is taking sulfhydryl-containing drugs.

Key words: Insulin autoimmune syndrome, Hypoglycemia, Graves disease, Methimazole

京ICP 备07035254号-20
Copyright © Chinese Journal of Diagnostics(Electronic Edition), All Rights Reserved.
Tel: 0537-3616261 E-mail: zhzdxzz@126.com
Powered by Beijing Magtech Co. Ltd